APOE and Alzheimer disease: In the search for blood-based biomarkers of AD with the capacity to distinguish AD from non-AD patients and also to distinguish the different APOE genotypes, we first investigated which proteins vary in the hippocampus of AD patients as a function of APOE genotype and AD status (that is, diseased versus nondiseased).